Inactive Instrument

Press Releases EXOPHARM

Equities

Exopharm : Appendix 4D and Half Year Report for period 31 December 2021	22-02-25	PU
Exopharm : Response to ASX Query	22-02-03	PU
Exopharm : Independent Plexaris and Cevaris testing shows positive and unique results	20-02-13	AQ
Exopharm : First Dosing in Exopharm’s PLEXOVAL Exosome Wound Healing Human Study	20-01-29	BU
Exopharm : Backs Regulatory Crackdown on Unapproved Exosome Products	19-12-19	BU

No results for this search